Express News | E-Home Household Services Holdings Signs Cleaning Service Agreements With Several Property Companies; Total Value Over RMB6M
Benzinga55minutes ago
Express News | E-Home Household Services Holdings Limited Signs Cleaning Service Agreements With Several Property Companies, Including Golden Emperor Properties, Totaling More Than RMB 6 Million
Reuters58minutes ago
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
PR Newswire08:00 ET
INOVIO to Participate in Upcoming Investor Conferences in May
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
PR Newswire08:00 ET
Express News | Gilead : Barclays Cuts Target Price to $76 From $80
Reuters06:28 ET
Gilead Sciences: Hold Rating With Cautious Outlook Amidst Market Challenges and Growth Uncertainties
TipRanks05:45 ET
Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceApr 27 10:29 ET
Analysts Are Neutral on These Healthcare Stocks: Edwards Lifesciences (EW), Gilead Sciences (GILD)
TipRanksApr 27 00:20 ET
Gilead Sciences To Go Ex-Dividend On June 14th, 2024 With 0.77 USD Dividend Per Share
April 27th - $Gilead Sciences(GILD.US)$ is trading ex-dividend on June 14th, 2024. Shareholders of record on June 14th, 2024 will receive 0.77 USD dividend per share on June 27th, 2024. The ex-div
moomoo NewsApr 26 19:40 ET
Emergent Biosolutions Enhances Executive Retention Bonuses
TipRanksApr 26 16:44 ET
Express News | Inovio Pharmaceuticals Form 13G Shows Deep Track Capital, LP Reported A 9.99% Stake In The Co As Of April, 16, 2024
BenzingaApr 26 16:05 ET
Express News | Deep Track Capital, LP Reports 9.99% Passive Stake in Inovio Pharmaceuticals Inc as of April 16 - SEC Filing
ReutersApr 26 16:03 ET
Options Corner: Gilead Sciences Sees Deep-Pocketed Investors Take Bullish Stance
Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:GILD), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga un
BenzingaApr 26 15:45 ET
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Aon plc (NYSE:AON) fell sharply during Friday's session after the company reported worse-than-expected quarterly financial results.Aon posted adjusted earnings of $5.66 per share, missing ma
BenzingaApr 26 13:56 ET
Gilead Sciences Price Target Cut to $85.00/Share From $90.00 by TD Cowen
Gilead Sciences Price Target Cut to $85.00/Share From $90.00 by TD Cowen
Dow JonesApr 26 13:35 ET
Gilead Sciences Is Maintained at Sector Perform by RBC Capital
Gilead Sciences Is Maintained at Sector Perform by RBC Capital
Dow JonesApr 26 11:57 ET
Express News | RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $74
BenzingaApr 26 11:46 ET
Gilead Sciences Declares $0.77 Dividend
Seeking AlphaApr 26 10:26 ET
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Seeking AlphaApr 26 10:00 ET
Morgan Stanley Adjusts Price Target on Gilead Sciences to $78 From $80
Gilead Sciences (GILD) has an average rating of outperform and price targets ranging from $69 to $121, according to analysts polled by Capital IQ. Price: 64.76, Change: -0.51, Percent Change: -0.78
MT NewswiresApr 26 09:59 ET